Zobrazeno 1 - 10
of 1 644
pro vyhledávání: '"Non-invasive Prenatal Testing"'
Publikováno v:
Reproductive Medicine, Vol 5, Iss 2, Pp 81-89 (2024)
Background: This study’s aim was to determine whether diminished oocyte reserve (DOR) increases the risk of having a fetus with trisomy 13, 18, or 21 at 10 weeks as evaluated by non-invasive prenatal testing (NIPT) and to evaluate the confounding e
Externí odkaz:
https://doaj.org/article/293862ed15fe46a495ffd488e4dd1a54
Autor:
Elena Evelina STOICA, Laurentiu Camil BOHILTEA, Delia-Maria Gradinaru-FOMETESCU, Monica Mihaela CIRSTOIU
Publikováno v:
Modern Medicine, Vol 31, Iss 2, Pp 187-190 (2024)
Non-invasive prenatal testing (NIPT), since its introduction in 2011, has revolutionized prenatal screening, becoming widely used globally and replacing traditional screening methods in developed countries. The accuracy of NIPT in detecting aneuploid
Externí odkaz:
https://doaj.org/article/7b4455f8b9084622a5c6775a0dd23eee
Autor:
Molly Johnston, Lisa Hui, Hilary Bowman-Smart, Michelle Taylor-Sands, Mark D. Pertile, Catherine Mills
Publikováno v:
BMC Pregnancy and Childbirth, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Non-invasive prenatal testing (NIPT) has been clinically available in Australia on a user-pays basis since 2012. There are numerous providers, with available tests ranging from targeted NIPT (only trisomies 21, 18, and 13 +/- sex
Externí odkaz:
https://doaj.org/article/d02ce23793ef4a99ac8acfe92b81de40
Autor:
Li, Shaogang a, b, 1, Lin, Yu b, d, 1, Su, Fengxia b, 1, Hu, Xintao b, Li, Lingguo b, Yan, Wei b, e, Zhang, Yan b, Zhuo, Min a, Gao, Ya b, ⁎⁎⁎, Jin, Xin b, c, ⁎⁎, Zhang, Haiqiang b, ⁎
Publikováno v:
In Clinica Chimica Acta 30 January 2025 566
Autor:
Amerigo Ferrari, Federico Pennestrì, Manila Bonciani, Giuseppe Banfi, Milena Vainieri, Rossella Tomaiuolo
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology: X, Vol 23, Iss , Pp 100327- (2024)
Introduction: Pregnant women can choose from different prenatal genetic tests throughout their maternity journey. We aim to investigate the clinical, societal, and economic determinants influencing the selection of different options (non-invasive, in
Externí odkaz:
https://doaj.org/article/7bc27c3165534352bede7448f06b1297
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundPolygenic risk scores (PRS) serve as valuable tools for connecting initial genetic discoveries with clinical applications in disease risk estimation. However, limited studies have explored the association between PRS and gestational diabete
Externí odkaz:
https://doaj.org/article/569a192dc10f4288897ccc3cb486777a
Autor:
Sydney A. Lau, Romy I. Fawaz, Robert Rigobello, Shahad Bawazeer, Nouf M. Alajaji, Eissa Faqeih, Yanchun Li, Yanming Feng, Fan Xia, Christine M. Eng, Malak Abedalthagafi
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Cell-free fetal DNA (cffDNA) screening is a valuable tool in clinical practice for detecting chromosomal abnormalities and autosomal dominant (AD) conditions. This study introduces a novel proof-of-concept assay designed for autosomal recessive (AR)
Externí odkaz:
https://doaj.org/article/913f08a699d745fba7a63950cd92ee46
Autor:
Wafik, Mohamed a, Pendlebury-Watt, Alice b, Price, Kelly c, Tomlinson, Charlotte a, Fowler, Emma b, Chandler, Natalie d, Holder-Espinasse, Muriel a, ⁎
Publikováno v:
In Best Practice & Research Clinical Obstetrics & Gynaecology December 2024 97
Autor:
Sobol, Maria a, b, Aravidis, Christos a, b, Hessel, Hugo c, Lindqvist, Anna d, Baranowska Körberg, Izabella a, b, ⁎
Publikováno v:
In European Journal of Obstetrics & Gynecology and Reproductive Biology November 2024 302:370-374
Publikováno v:
In European Journal of Obstetrics & Gynecology and Reproductive Biology November 2024 302:149-154